Walter Noordzij
dr.
In my profession as a nuclear medicine physician, I’m involved in both clinical and scientific applications of nuclear medicine and radiology modalities. My main interests include haematology, general oncology, radio-immunotherapy, and especially the implementation of new therapeutic strategies. Currently, I have a special interest in imaging post-transplant lymphoproliferative disease, as well as radio-immunotherapy in chemotherapy refractory (non)-Hodgkin’s lymphoma.
Reflections on the PEACE V-STORM trial
Published in: Lancet Oncology
Access to document
10.1016/S1470-2045(25)00365-1
Motion-resolved parametric imaging derived from short dynamic [18F]FDG PET/CT scans.
Published in: Physica medica-European journal of medical physics
Access to document
10.1016/j.ejmp.2025.105010
document
PURPOSE: This study aims to assess the added value of utilizing short-dynamic whole-body PET/CT scans and implementing motion correction before quantifying metabolic rate, offering more insights into physiological processes. While this approach may not be commonly adopted, addressing motion effects is crucial due to their demonstrated potential to cause significant errors in parametric imaging. METHODS: A 15-minute dynamic FDG PET acquisition protocol was utilized for four lymphoma patients undergoing therapy evaluation. Parametric imaging was obtained using a population-based input function (PBIF) derived from twelve patients with full 65-minute...
Alessia Artesani, Joyce van Sluis, Laura Providência, Johannes H van Snick, Riemer H J A Slart, Walter Noordzij, Charalampos Tsoumpas
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice.
Published in: Journal of Nuclear Medicine
Access to document
10.2967/jnumed.125.269746
document
223Ra-dichloride ( 223Ra) is an approved therapeutic option for patients with metastatic castration-resistant prostate cancer (mCRPC) who have symptomatic bone metastases. After an initial course of 6 223Ra injections, treatment may be repeated. The purpose of this study was to evaluate the safety and efficacy of 223Ra retreatment of mCRPC in a real-world population. Methods: This multicenter, retrospective cohort study included patients who had mCRPC and bone metastases who previously received 6 consecutive injections of 223Ra and received at least 1 223Ra retreatment injection between 2014 and 2024....
Joost H H M van Riel, Maarten L Donswijk, Christel Brouwer, Winald R Gerritsen, T T Ha Tan-Phan, Paul W L Thimister, Walter Noordzij, Erik T Te Beek, Laurence J C van Warmerdam, Andries M Bergman, Inge M van Oort, Dirk N J Wyndaele, Maarten J van der Doelen
Separation of simultaneously acquired [89Zr]atezolizumab and [18F]FDG PET scans
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-025-07340-w
document
Zekai Li, Janneke W de Boer, Tom van Meerten, Anne G H Niezink, Walter Noordzij, Adriaan A Lammertsma, Charalampos Tsoumpas, Adrienne H Brouwers
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View
Published in: European urology open science
Access to document
10.1016/j.euros.2025.03.007
document
Background and objective: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) and new treatment modalities have expanded the possibilities for diagnosing and managing metastatic prostate cancer, but have also raised questions about their implementation in daily clinical practice. We sought consensus on definitions, preferred imaging modality for staging, and treatment selection in the era of next-generation imaging. Methods: A modified Delphi method involved two voting rounds and a face-to-face multidisciplinary meeting with 40 Dutch prostate cancer (PCa) experts. Consensus was reached if ≥75% of the panellists chose the...
Daniela E. Oprea-Lager, Tessa van Elst, Shafak Aluwini, Els Dewulf, Henk van der Poel, Herman Stoevelaar, Chris H. Bangma, Aart Beeker, Steve Boudewijns, Tom Budiharto, Igle Jan de Jong, Kim C. de Vries, Maarten L. Donswijk, Jurgen J. Fütterer, Paul Hamberg, Linda Heijmen, Robert J. Hoekstra, Thomas M.A. Kerkhofs, Jules Lavalaye, Daphne Luijendijk de BruinWalter Noordzij, Irma M. Oving, Debbie G.J. Robbrecht, Eva E. Schaake, Addy C.M. van de Luijtgaarden, Roderick C.N. van den Bergh, Franchette van den Berkmortel, Tom van der Hulle, Johannes C.K. van der Mijn, Joyce M. van Dodewaard-de Jong, Michel van Kruchten, Pim J. van Leeuwen, Evert van Limbergen, R. Jeroen A. van Moorselaar, Inge M. van Oort, Joep G.H. van Roermund, Robert J. van Soest, Theo Veninga, André N. Vis, Jens Voortman, Peter Paul M. Willemse, Derya Yakar, Niven Mehra